{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:31:59Z","timestamp":1792369919390,"version":"4.4.0"},"reference-count":94,"publisher":"The Journal of Rheumatology","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>An estimated 40\u201350% of patients with psoriasis (PsO) have psoriatic nail disease, which is associated with and directly contributes to a greater clinical burden and worse quality of life in these patients. In this review, we examine how recent advances in the use of new diagnostic techniques have led to improved understanding of the link between nail and musculoskeletal manifestations of psoriatic disease (PsD; e.g., enthesitis, arthritis) and we review targeted therapies for nail PsO (NP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a literature search to identify which systemic therapies approved for the treatment of PsO and\/or psoriatic arthritis (PsA) have been evaluated for the treatment of NP, either as a primary or secondary outcome. A total of 1546 articles were identified on February18, 2019, and evaluated for relevance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included findings from 66 articles on systemic therapies for the treatment of NP in PsD. With several scoring systems available for the evaluation of psoriatic nail disease, including varied subtypes and application of the Nail Psoriasis Area Severity Index, there was a high level of methodological heterogeneity across studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NP is an important predictor of enthesitis, which is associated with the early stages of PsA; therefore, it is important for rheumatologists and dermatologists to accurately diagnose and treat NP to prevent nail damage and potentially delay the onset and progression of joint disease. Further research is needed to address the lack of both standardized NP scoring systems and well-defined treatment guidelines to improve management of PsD.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.201471","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T13:42:59Z","timestamp":1613396579000},"page":"1208-1220","source":"Crossref","is-referenced-by-count":57,"title":["Nail Psoriasis: Diagnosis, Assessment, Treatment Options, and Unmet Clinical Needs"],"prefix":"10.3899","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1335-3131","authenticated-orcid":false,"given":"Gurjit S.","family":"Kaeley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1473-1715","authenticated-orcid":false,"given":"Lihi","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8792-4449","authenticated-orcid":false,"given":"Sibel Zehra","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Bakewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"2022062114102985000_48.8.1208.1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.339"},{"key":"2022062114102985000_48.8.1208.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.11.013"},{"key":"2022062114102985000_48.8.1208.3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ad.2011.02.007","article-title":"[Nail psoriasis in individuals with psoriasis vulgaris: a study of 661 patients]. [Article in Spanish]","volume":"102","author":"Armesto","year":"2011","journal-title":"Actas Dermosifiliogr"},{"key":"2022062114102985000_48.8.1208.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09831.x"},{"key":"2022062114102985000_48.8.1208.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.07.073"},{"key":"2022062114102985000_48.8.1208.6","doi-asserted-by":"publisher","DOI":"10.1159\/000313974"},{"key":"2022062114102985000_48.8.1208.7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000316179","article-title":"Treatment and management of psoriasis with nail involvement: a focus on biologic therapy","volume":"221","author":"Langley","year":"2010","journal-title":"Dermatology"},{"key":"2022062114102985000_48.8.1208.8","doi-asserted-by":"publisher","DOI":"10.1007\/s10227-002-0143-0"},{"key":"2022062114102985000_48.8.1208.9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaad.2019.01.072","article-title":"Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: a dermatologist and nail expert group consensus","volume":"81","author":"Rigopoulos","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2022062114102985000_48.8.1208.10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.semarthrit.2014.05.002","article-title":"Psoriatic arthritis and nail changes: exploring the relationship","volume":"44","author":"Sandre","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"2022062114102985000_48.8.1208.11","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/jdv.12368","article-title":"Nail psoriasis, the unknown burden of disease","volume":"28","author":"Klaassen","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022062114102985000_48.8.1208.12","first-page":"S7","article-title":"Nail psoriasis","volume":"33","author":"Manhart","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2022062114102985000_48.8.1208.13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5114\/reum.2017.68912","article-title":"Nail involvement in psoriatic arthritis","volume":"55","author":"Sobolewski","year":"2017","journal-title":"Reumatologia"},{"key":"2022062114102985000_48.8.1208.14","doi-asserted-by":"publisher","DOI":"10.1159\/000246274"},{"key":"2022062114102985000_48.8.1208.15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel214"},{"key":"2022062114102985000_48.8.1208.16","doi-asserted-by":"publisher","DOI":"10.1159\/000343607"},{"key":"2022062114102985000_48.8.1208.17","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10067-016-3319-5","article-title":"Psoriatic nail involvement and its relationship with distal interphalangeal joint disease","volume":"35","author":"Lai","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2022062114102985000_48.8.1208.18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ad.2015.02.005","article-title":"Nail psoriasis as a predictor of the development of psoriatic arthritis","volume":"106","author":"Raposo","year":"2015","journal-title":"Actas Dermosifiliogr"},{"key":"2022062114102985000_48.8.1208.19","first-page":"708","article-title":"Lessons learned from imaging on enthesitis in psoriatic arthritis","volume":"19","author":"Watad","year":"2017","journal-title":"Isr Med Assoc J"},{"key":"2022062114102985000_48.8.1208.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1970.tb02205.x"},{"key":"2022062114102985000_48.8.1208.21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/1346-8138.12990","article-title":"Accelerated nail elongation speed in psoriasis patients during treatment","volume":"42","author":"Honma","year":"2015","journal-title":"J Dermatol"},{"key":"2022062114102985000_48.8.1208.22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5114\/reum.2017.66687","article-title":"Nail psoriasis \u2013 what a rheumatologist should know about","volume":"55","author":"Nieradko-Iwanicka","year":"2017","journal-title":"Reumatologia"},{"key":"2022062114102985000_48.8.1208.23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1590\/abd1806-4841.20142633","article-title":"Nail psoriasis: a review of the literature","volume":"89","author":"Schons","year":"2014","journal-title":"An Bras Dermatol"},{"key":"2022062114102985000_48.8.1208.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06862.x"},{"key":"2022062114102985000_48.8.1208.25","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/cup.13334","article-title":"Clinical and histological spectrum of nail psoriasis: a cross-sectional study","volume":"45","author":"Kaul","year":"2018","journal-title":"J Cutan Pathol"},{"key":"2022062114102985000_48.8.1208.26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.11152\/mu.2013.2066.183.hgh","article-title":"High-frequency sonography in the evaluation of nail psoriasis","volume":"18","author":"Marina","year":"2016","journal-title":"Med Ultrason"},{"key":"2022062114102985000_48.8.1208.27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1590\/abd1806-4841.20164296","article-title":"Incidence, clinical manifestations and clipping of nail psoriasis in the dermatology center of the Hospital Universitario Evangelico de Curitiba","volume":"91","author":"Garbers","year":"2016","journal-title":"An Bras Dermatol"},{"key":"2022062114102985000_48.8.1208.28","first-page":"138","article-title":"Clinical pearl: early diagnosis of nail psoriasis and psoriatic arthritis","volume":"99","author":"Lipner","year":"2017","journal-title":"Cutis"},{"key":"2022062114102985000_48.8.1208.29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000449230","article-title":"Vascular features of nail psoriasis using dynamic optical coherence tomography","volume":"2","author":"Aldahan","year":"2017","journal-title":"Skin Appendage Disord"},{"key":"2022062114102985000_48.8.1208.30","doi-asserted-by":"publisher","DOI":"10.1159\/000329434"},{"key":"2022062114102985000_48.8.1208.31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4103\/0019-5154.135470","article-title":"Nail psoriasis: the journey so far","volume":"59","author":"Dogra","year":"2014","journal-title":"Indian J Dermatol"},{"key":"2022062114102985000_48.8.1208.32","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/1346-8138.13752","article-title":"Dermoscopic features of nail psoriasis treated with biologics","volume":"44","author":"Hashimoto","year":"2017","journal-title":"J Dermatol"},{"key":"2022062114102985000_48.8.1208.33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5114\/ada.2017.65618","article-title":"A study of dermoscopic features of nail psoriasis","volume":"34","author":"Yorulmaz","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"key":"2022062114102985000_48.8.1208.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.02.010"},{"key":"2022062114102985000_48.8.1208.35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jamadermatol.2018.0793","article-title":"Efficacy of guselkumab compared with adalimumab and placebo for psoriasis in specific body regions: a secondary analysis of 2 randomized clinical trials","volume":"154","author":"Foley","year":"2018","journal-title":"JAMA Dermatol"},{"key":"2022062114102985000_48.8.1208.36","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12632"},{"key":"2022062114102985000_48.8.1208.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.11.041"},{"key":"2022062114102985000_48.8.1208.38","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20577"},{"key":"2022062114102985000_48.8.1208.39","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)00910-1"},{"key":"2022062114102985000_48.8.1208.40","first-page":"123","article-title":"The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis","volume":"34","author":"Cassell","year":"2007","journal-title":"J Rheumatol"},{"key":"2022062114102985000_48.8.1208.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.11.044"},{"key":"2022062114102985000_48.8.1208.42","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.9.834"},{"key":"2022062114102985000_48.8.1208.43","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh198"},{"key":"2022062114102985000_48.8.1208.44","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05725.x"},{"key":"2022062114102985000_48.8.1208.45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000068469","article-title":"Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study","volume":"206","author":"Cannav\u00f2","year":"2003","journal-title":"Dermatology"},{"key":"2022062114102985000_48.8.1208.46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000018281","article-title":"Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study","volume":"199","author":"de Jong","year":"1999","journal-title":"Dermatology"},{"key":"2022062114102985000_48.8.1208.47","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/bjd.12664","article-title":"Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes","volume":"170","author":"Augustin","year":"2014","journal-title":"Br J Dermatol"},{"key":"2022062114102985000_48.8.1208.48","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/bjd.12354","article-title":"Nail psoriasis: a questionnaire-based survey","volume":"169","author":"Klaassen","year":"2013","journal-title":"Br J Dermatol"},{"key":"2022062114102985000_48.8.1208.49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-3083.2009.03344.x","article-title":"Development and validation of nail psoriasis quality of life scale (NPQ10)","volume":"24","author":"Ortonne","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022062114102985000_48.8.1208.50","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20691"},{"key":"2022062114102985000_48.8.1208.51","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100857"},{"key":"2022062114102985000_48.8.1208.52","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110839"},{"key":"2022062114102985000_48.8.1208.53","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12562"},{"key":"2022062114102985000_48.8.1208.54","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/bjd.15026","article-title":"Natural history of isolated nail psoriasis and its role as a risk factor for the development of psoriatic arthritis: a single-centre cross-sectional study","volume":"176","author":"Balestri","year":"2017","journal-title":"Br J Dermatol"},{"key":"2022062114102985000_48.8.1208.55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11926-015-0540-1","article-title":"Clinical risk factors for the development of psoriatic arthritis among patients with psoriasis: a review of available evidence","volume":"17","author":"Ogdie","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"2022062114102985000_48.8.1208.56","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200478"},{"key":"2022062114102985000_48.8.1208.57","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/jdv.15035","article-title":"Subclinical enthesopathy of extensor digitorum tendon is highly prevalent and associated with clinical and ultrasound alterations of the adjacent fingernails in patients with psoriatic disease","volume":"32","author":"Moya Alvarado","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022062114102985000_48.8.1208.58","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/ddg.12989","article-title":"Nail involvement can predict enthesopathy in patients with psoriasis","volume":"14","author":"Castellanos-Gonz\u00e1lez","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"2022062114102985000_48.8.1208.59","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00296-018-4222-y","article-title":"To what extend is nail ultrasound discriminative between psoriasis, psoriatic arthritis and healthy subjects?","volume":"39","author":"Naredo","year":"2019","journal-title":"Rheumatol Int"},{"key":"2022062114102985000_48.8.1208.60","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10067-019-04437-0","article-title":"The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions","volume":"38","author":"Idolazzi","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2022062114102985000_48.8.1208.61","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jbspin.2016.10.005","article-title":"Detection of subclinical ultrasound enthesopathy and nail disease in patients at risk of psoriatic arthritis","volume":"84","author":"Acquitter","year":"2017","journal-title":"Joint Bone Spine"},{"key":"2022062114102985000_48.8.1208.62","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s00296-018-4160-8","article-title":"Assessment of nail unit structures by ultrasound in patients with psoriatic arthritis and their correlations with disease activity indices: a case-control study","volume":"38","author":"Mondal","year":"2018","journal-title":"Rheumatol Int"},{"key":"2022062114102985000_48.8.1208.63","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/jcm7120546","article-title":"Effect of methotrexate in the treatment of distal interphalangeal joint extensor tendon enthesopathy in patients with nail psoriasis","volume":"7","author":"Krajewska-W\u0142odarczyk","year":"2018","journal-title":"J Clin Med"},{"key":"2022062114102985000_48.8.1208.64","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140881"},{"key":"2022062114102985000_48.8.1208.65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jamadermatol.2014.2983","article-title":"Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation","volume":"151","author":"Crowley","year":"2015","journal-title":"JAMA Dermatol"},{"key":"2022062114102985000_48.8.1208.66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04349.x"},{"key":"2022062114102985000_48.8.1208.67","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/ijdvl.IJDVL_73_16","article-title":"Intramatricial injections for nail psoriasis: an open-label comparative study of triamcinolone, methotrexate, and cyclosporine","volume":"84","author":"Mittal","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2022062114102985000_48.8.1208.68","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/jdv.14033","article-title":"Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3","volume":"31","author":"van de Kerkhof","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022062114102985000_48.8.1208.69","first-page":"958","article-title":"Ixekizumab is effective in subjects with moderate to severe plaque psoriasis with significant nail involvement: results from UNCOVER-3","volume":"15","author":"Dennehy","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"2022062114102985000_48.8.1208.70","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/jdv.14738","article-title":"Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study","volume":"32","author":"Reich","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022062114102985000_48.8.1208.71","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/bjd.15831","article-title":"Reporting of outcomes in randomized controlled trials on nail psoriasis: a systematic review","volume":"178","author":"Busard","year":"2018","journal-title":"Br J Dermatol"},{"key":"2022062114102985000_48.8.1208.72","first-page":"1039","article-title":"Effectiveness of systemic treatment agents on psoriatic nails: a comparative study","volume":"12","author":"Demirsoy","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"2022062114102985000_48.8.1208.73","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2013.783561"},{"key":"2022062114102985000_48.8.1208.74","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2011.646939"},{"key":"2022062114102985000_48.8.1208.75","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2013.736960"},{"key":"2022062114102985000_48.8.1208.76","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/bjd.17351","article-title":"Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial","volume":"181","author":"Reich","year":"2018","journal-title":"Br J Dermatol"},{"key":"2022062114102985000_48.8.1208.77","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022062114102985000_48.8.1208.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.057"},{"key":"2022062114102985000_48.8.1208.79","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.40726","article-title":"Special article: 2018 American College of Rheumatology\/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis","volume":"71","author":"Singh","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2022062114102985000_48.8.1208.80","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaad.2017.08.029","article-title":"Adalimumab for nail psoriasis: efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial","volume":"78","author":"Elewski","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"2022062114102985000_48.8.1208.81","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2008.600"},{"key":"2022062114102985000_48.8.1208.82","doi-asserted-by":"publisher","DOI":"10.1177\/120347540400800208"},{"key":"2022062114102985000_48.8.1208.83","first-page":"916","article-title":"Improvement of quality of life and clinical usefulness of cyclosporin administration in patients with nail psoriasis","volume":"38","author":"Abe","year":"2011","journal-title":"J Dermatol"},{"key":"2022062114102985000_48.8.1208.84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03927.x"},{"key":"2022062114102985000_48.8.1208.85","first-page":"78","article-title":"Treatment of nail psoriasis with a modified regimen of steroid injections","volume":"18","author":"Saleem","year":"2008","journal-title":"J Coll Physicians Surg Pak"},{"key":"2022062114102985000_48.8.1208.86","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2013.13078"},{"key":"2022062114102985000_48.8.1208.87","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09546634.2018.1476647","article-title":"A randomized comparison of efficacy and safety of intralesional triamcinolone injection and clobetasol propionate ointment for psoriatic nails","volume":"30","author":"Boontaveeyuwat","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"2022062114102985000_48.8.1208.88","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03453.x"},{"key":"2022062114102985000_48.8.1208.89","first-page":"11","article-title":"Effectiveness of adalimumab in the treatment of scalp and nail affection in patients with moderate to severe plaque psoriasis in routine clinical practice","volume":"26","author":"Khobzey","year":"2017","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"2022062114102985000_48.8.1208.90","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/bjd.12060","article-title":"A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis","volume":"168","author":"Ortonne","year":"2013","journal-title":"B J Dermatol"},{"key":"2022062114102985000_48.8.1208.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.09.012"},{"key":"2022062114102985000_48.8.1208.92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08686.x"},{"key":"2022062114102985000_48.8.1208.93","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2011.607796"},{"key":"2022062114102985000_48.8.1208.94","doi-asserted-by":"publisher","DOI":"10.1159\/000334482"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.201471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T07:16:51Z","timestamp":1697872611000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.201471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":94,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,1]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.3899\/jrheum.201471"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.201471","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]}}}